Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Klein, Catherine J.
2002.
Nutrient Requirements For Preterm Infant Formulas.
The Journal of Nutrition,
Vol. 132,
Issue. 6,
p.
1395S.
Northrop-Clewes, C.A.
and
Thurnham, D.I.
2002.
The Nutrition Handbook for Food Processors.
p.
34.
Jacobs, Peter
and
Wood, Lucille
2003.
Vitamin B2.
Disease-a-Month,
Vol. 49,
Issue. 11,
p.
653.
Moat, Stuart J
Ashfield-Watt, Pauline A L
Powers, Hilary J
Newcombe, Robert G
and
McDowell, Ian F W
2003.
Effect of Riboflavin Status on the Homocysteine-lowering Effect of Folate in Relation to the MTHFR (C677T) Genotype.
Clinical Chemistry,
Vol. 49,
Issue. 2,
p.
295.
Perumal, Selvanathan Saravana
Shanthi, Palanivelu
and
Sachdanandam, Panchanadham
2005.
Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer.
Cancer Chemotherapy and Pharmacology,
Vol. 56,
Issue. 1,
p.
105.
Compher, Charlene
2005.
Clinical Nutrition.
p.
126.
Bates, C.J.
2005.
Encyclopedia of Human Nutrition.
p.
100.
Graham, Joanne M
Peerson, Janet M
Haskell, Marjorie J
Shrestha, Ram K
Brown, Kenneth H
and
Allen, Lindsay H
2005.
Erythrocyte Riboflavin for the Detection of Riboflavin Deficiency in Pregnant Nepali Women.
Clinical Chemistry,
Vol. 51,
Issue. 11,
p.
2162.
Perumal, Selvanathan Saravana
Shanthi, Palanivelu
and
Sachdanandam, Panchanadham
2005.
Energy-modulating vitamins – a new combinatorial therapy prevents cancer cachexia in rat mammary carcinoma.
British Journal of Nutrition,
Vol. 93,
Issue. 6,
p.
901.
Yuvaraj, Srinivasan
Premkumar, Vummidi Giridhar
Vijayasarathy, Kothandaraman
Gangadaran, Sitthu Govindaswamy Dinakaran
and
Sachdanandam, Panchanatham
2008.
Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin.
Cancer Chemotherapy and Pharmacology,
Vol. 61,
Issue. 6,
p.
933.
Almeida, Lana Carneiro
Tomita, Luciana Yuki
D'Almeida, Vânia
and
Cardoso, Marly Augusto
2008.
Preditores sócio-demográficos, de estilo de vida e gineco-obstétricos das concentrações séricas ou plasmáticas de homocisteína, ácido fólico e vitaminas B12 e B6 em mulheres de baixa renda de São Paulo, Brasil.
Cadernos de Saúde Pública,
Vol. 24,
Issue. 3,
p.
587.
Hoey, Leane
McNulty, Helene
and
Strain, JJ
2009.
Studies of biomarker responses to intervention with riboflavin: a systematic review.
The American Journal of Clinical Nutrition,
Vol. 89,
Issue. 6,
p.
1960S.
Yuvaraj, Srinivasan
Premkumar, Vummidi Gridhar
Shanthi, Palanivel
Vijayasarathy, Kothandaraman
Gangadaran, Sitthu Govindaswamy Dinakaran
and
Sachdanandam, Panchanatham
2009.
Effect of Coenzyme Q10, Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles.
Breast Cancer Research and Treatment,
Vol. 114,
Issue. 2,
p.
377.
Perlmutter, David
2009.
Food and Nutrients in Disease Management.
Mushtaq, Sohail
Su, Han
Hill, Marilyn HE
and
Powers, Hilary J
2009.
Erythrocyte pyridoxamine phosphate oxidase activity: a potential biomarker of riboflavin status?.
The American Journal of Clinical Nutrition,
Vol. 90,
Issue. 5,
p.
1151.
Tucker, K.L.
2009.
Food for the Ageing Population.
p.
399.
ASH, ANTHONY
and
WILBEY, ANDREW
2010.
The nutritional significance of cheese in the UK diet.
International Journal of Dairy Technology,
Vol. 63,
Issue. 3,
p.
305.
Petteys, Brian J.
and
Frank, Elizabeth L.
2011.
Rapid determination of vitamin B2 (riboflavin) in plasma by HPLC.
Clinica Chimica Acta,
Vol. 412,
Issue. 1-2,
p.
38.
Sinigaglia-Coimbra, Rita
Lopes, Antonio Carlos
and
Coimbra, Cicero G.
2011.
Handbook of Behavior, Food and Nutrition.
p.
2427.
Garrido‐Maraver, Juan
Cordero, Mario D
Moñino, Irene Domínguez
Pereira‐Arenas, Sheila
Lechuga‐Vieco, Ana V
Cotán, David
De la Mata, Mario
Oropesa‐Ávila, Manuel
De Miguel, Manuel
Bautista Lorite, Juan
Rivas Infante, Eloy
Álvarez‐Dolado, Manuel
Navas, Plácido
Jackson, Sandra
Francisci, Silvia
and
Sánchez‐Alcázar, José A
2012.
Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease.
British Journal of Pharmacology,
Vol. 167,
Issue. 6,
p.
1311.